We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
+16.37%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$17.4B
AUM Growth
+$1.47B
(+9.2%)
Cap. Flow
-$683M
Cap. Flow
% of AUM
-3.93%
Top 10 Holdings %
Top 10 Hldgs %
15.77%
Holding
1,268
New
129
Increased
603
Reduced
478
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$38.9M |
| 2 |
Global Payments
GPN
|
+$28.7M |
| 3 |
Cummins
CMI
|
+$23.6M |
| 4 |
Accenture
ACN
|
+$21.2M |
| 5 |
Adobe
ADBE
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$174M |
| 2 |
Alibaba
BABA
|
+$56.2M |
| 3 |
Autodesk
ADSK
|
+$55M |
| 4 |
Oracle
ORCL
|
+$42.4M |
| 5 |
Vanguard Morningstar Value ETF
VTV
|
+$41.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.82% |
| 2 | Financials | 14% |
| 3 | Healthcare | 13.4% |
| 4 | Industrials | 10.6% |
| 5 | Consumer Discretionary | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Cytokinetics
CYTK
$10.6B
| $392K | ﹤0.01% |
+18,882
| New | +$345K |
|
1152
Amplify Blockchain Technology ETF
BLOK
$1.03B
| $390K | ﹤0.01% |
+11,149
| New | +$316K |
|
|
IPG
1153
DELISTED
Interpublic Group of Companies
IPG
| $390K | ﹤0.01% |
16,584
-320
| -2% | -$6.71K |
|
|
CALY
1154
Callaway Golf Company
CALY
$3.28B
| $390K | ﹤0.01% |
+16,260
| New | +$332K |
|
1155
Steel Dynamics
STLD
$36.2B
| $389K | ﹤0.01% |
+10,547
| New | +$366K |
|
1156
KB Home
KBH
$3.5B
| $386K | ﹤0.01% |
11,509
-17,380
| -60% | -$624K |
|
1157
iShares Gold Trust
IAU
$62.8B
| $377K | ﹤0.01% |
10,394
-1,343
| -11% | -$48.1K |
|
1158
Commercial Metals
CMC
$7.53B
| $372K | ﹤0.01% |
18,127
-724
| -4% | -$15K |
|
1159
iShares Global REIT ETF
REET
$5.14B
| $371K | ﹤0.01% |
15,496
-96
| -0.6% | -$2.16K |
|
|
JBGS
1160
JBG SMITH
JBGS
$846M
| $368K | ﹤0.01% |
11,765
+217
| +2% | +$6.25K |
|
|
AERI
1161
DELISTED
Aerie Pharmaceuticals
AERI
| $348K | ﹤0.01% |
+25,739
| New | +$311K |
|
1162
E.W. Scripps
SSP
$270M
| $347K | ﹤0.01% |
+22,721
| New | +$280K |
|
|
UCTT
1163
Ultra Clean Holdings
UCTT
$3.12B
| $347K | ﹤0.01% |
+11,151
| New | +$311K |
|
1164
Scholastic
SCHL
$774M
| $346K | ﹤0.01% |
13,856
+1,204
| +10% | +$27.7K |
|
1165
Lexicon Pharmaceuticals
LXRX
$1.03B
| $345K | ﹤0.01% |
+100,993
| New | +$193K |
|
|
ITCI
1166
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $342K | ﹤0.01% |
+10,758
| New | +$283K |
|
1167
Cactus
WHD
$3.63B
| $329K | ﹤0.01% |
+12,613
| New | +$286K |
|
1168
Benchmark Electronics
BHE
$2.66B
| $326K | ﹤0.01% |
12,077
+1,226
| +11% | +$29K |
|
1169
Old National Bancorp
ONB
$10.2B
| $324K | ﹤0.01% |
+19,548
| New | +$299K |
|
1170
Fox Class B
FOX
$22.1B
| $321K | ﹤0.01% |
11,123
-658
| -6% | -$18.2K |
|
1171
Seacoast Banking Corp of Florida
SBCF
$3.3B
| $321K | ﹤0.01% |
+10,898
| New | +$264K |
|
|
VGR
1172
DELISTED
Vector Group Ltd.
VGR
| $316K | ﹤0.01% |
38,258
+2,523
| +7% | +$19.8K |
|
1173
STAG Industrial
STAG
$7.5B
| $314K | ﹤0.01% |
10,011
-110,780
| -92% | -$3.46M |
|
1174
Pembina Pipeline
PBA
$29.3B
| $311K | ﹤0.01% |
13,150
+220
| +2% | +$5.17K |
|
|
IMGN
1175
DELISTED
Immunogen Inc
IMGN
| $310K | ﹤0.01% |
48,078
-189,106
| -80% | -$1.1M |
|
Similar funds
BC
CBU
Natixis Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Natixis Advisors held 1,268 positions worth $17.4B, up 9.2% from $15.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Natixis Advisors withdrew a net $683M in Q4 2020, closing 57 positions and reducing 478 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $39.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Natixis Advisors opened a new position in Tesla worth $28.5M.
- Natixis Advisors's largest Q4 2020 buy was Tesla: 121,236 shares worth $28.5M.
- Natixis Advisors added most to Unilever in Q4 2020, an estimated $38.9M increase.
- Natixis Advisors's biggest Q4 2020 reduction was Vanguard Total Bond Market, cutting an estimated $174M.
- Natixis Advisors fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $39.4M.
- Natixis Advisors's ten largest holdings make up 16% of its $17.4B portfolio in Q4 2020.
- Natixis Advisors opened 129 new positions and closed 57 in Q4 2020.
- Natixis Advisors's portfolio value rose 9.2% quarter-over-quarter to $17.4B.
Based on Natixis Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.